Registered entities
HIMS, INC.
Reg. No. 821928388United States
HIMS & HERS HEALTH, INC
Reg. No. 3516095United States
Reputation
Customer rating 3.0 / 5 across 8,693 reviews.
Web presence
Audience by country — top 5 markets by share of visits.
| Country | Share |
|---|---|
| United States | 83.5% |
| India | 3.9% |
| Canada | 1.2% |
| United Kingdom | 1% |
| Germany | 0.8% |
Social engagement
Social engagement: 231.3K social following, 6 posts in the last 12 months — below the industry typical range.
Investor mix
18 investors on record; lead investors include Thrive Capital, 8VC; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 13 | 72% |
| Private equity | 4 | 22% |
| Accelerator & incubator | 1 | 6% |
Share of voice
Share of voice in United States: 30.1% of web traffic across its competitive set; worldwide: 21.8%.
Recent activity
21 May 2026
Product launch
Generical Semaglutide
7 May 2026
Product launch
Labs AI
23 Apr 2026
Milestone
regulatory